Login
Super Investors Horton Capital Management, LLC
HC

Horton Capital Management, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$44.9M
Positions
5
Quarter ended
December 31, 2021
Filed
February 11, 2022

Reported portfolio value by quarter (9 quarters reported)

$133M $44.9M
Q4 19 Q2 20 Q4 20 Q2 21 Q4 21

$103M in Q4 2019 → $44.9M now. Hover for any quarter.

Holdings

As reported for the quarter ended December 31, 2021. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
RM Repro Med Sys Inc 72.2% Added 0.0% 10,790,895 $32.4M
Urogen Pharma Ltd 14.9% Added 2.9% 704,749 $6.7M
WT Wireless Telecom Group Inc 7.4% Trimmed 2.9% 1,514,509 $3.33M
Safeguard Scientifics Inc 2.9% Unchanged 177,386 $1.3M
C Cynergistek Inc 2.5% Added 5.7% 791,819 $1.14M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q4 2021

quarter ended December 31, 2021 · filed February 11, 2022

Company Action Shares changed Value of change % of portfolio
C Cyberoptics Corp Exited −27,612 −$982K —
Urogen Pharma Ltd Added +20,000 +$190K 14.9%
WT Wireless Telecom Group Inc Trimmed −45,249 −$99.6K 7.4%
Creative Realities Inc Exited −71,425 −$96K —
C Cynergistek Inc Added +42,402 +$61K 2.5%
RM Repro Med Sys Inc Added +5,000 +$15K 72.2%

Q3 2021

quarter ended September 30, 2021 · filed November 12, 2021

Company Action Shares changed Value of change % of portfolio
Safeguard Scientifics Inc Trimmed −304,722 −$2.71M 3.2%
WT Wireless Telecom Group Inc Trimmed −626,046 −$1.3M 6.5%
C Cyberoptics Corp New +27,612 +$982K 2.0%
Urogen Pharma Ltd Added +56,674 +$953K 23.3%
RM Repro Med Sys Inc Added +40,263 +$115K 62.1%
C Cynergistek Inc Added +39,413 +$70.9K 2.7%

Q2 2021

quarter ended June 30, 2021 · filed August 13, 2021

Company Action Shares changed Value of change % of portfolio
Urogen Pharma Ltd Added +8,800 +$134K 13.0%
RM Repro Med Sys Inc Added +4,038 +$18.7K 67.6%

Q1 2021

quarter ended March 31, 2021 · filed May 12, 2021

Company Action Shares changed Value of change % of portfolio
Urogen Pharma Ltd Added +228,847 +$4.46M 20.7%
RM Repro Med Sys Inc Trimmed −1,123,110 −$3.95M 64.8%
Blink Charging Co Exited −4,800 −$205K —
WT Wireless Telecom Group Inc Trimmed −20,000 −$34K 6.4%

Q4 2020

quarter ended December 31, 2020 · filed February 16, 2021

Company Action Shares changed Value of change % of portfolio
Safeguard Scientifics Inc Trimmed −692,758 −$4.42M 3.5%
M Misonix Inc Exited −55,000 −$645K —
Urogen Pharma Ltd Added +15,000 +$270K 8.1%
Blink Charging Co New +4,800 +$205K 0.2%
Creative Realities Inc Exited −205,964 −$202K —
RM Repro Med Sys Inc Added +32,285 +$194K 82.4%
C Cynergistek Inc Added +59,588 +$86.4K 1.2%

Q3 2020

quarter ended September 30, 2020 · filed November 13, 2020

Company Action Shares changed Value of change % of portfolio
RM Repro Med Sys Inc Trimmed −344,594 −$2.49M 82.1%
C Cynergistek Inc Trimmed −303,872 −$477K 1.0%
Urogen Pharma Ltd Trimmed −8,000 −$154K 7.0%
Creative Realities Inc Trimmed −114,374 −$112K 0.2%
Safeguard Scientifics Inc Added +3,415 +$18.7K 6.2%

Q2 2020

quarter ended June 30, 2020 · filed August 12, 2020

Company Action Shares changed Value of change % of portfolio
Urogen Pharma Ltd Added +131,809 +$3.44M 7.5%
Creative Realities Inc Trimmed −308,923 −$770K 0.6%
M Misonix Inc New +55,000 +$746K 0.6%
Safeguard Scientifics Inc Added +93,156 +$652K 6.2%
RM Repro Med Sys Inc Added +1,000 +$8.98K 82.4%

Q1 2020

quarter ended March 31, 2020 · filed April 27, 2020

Company Action Shares changed Value of change % of portfolio
Urogen Pharma Ltd Added +142,949 +$2.55M 4.2%
RM Repro Med Sys Inc Trimmed −124,782 −$936K 86.4%
C Cynergistek Inc Added +124,481 +$176K 1.3%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support